Effects of teclistamab and talquetamab on soluble BCMA levels in patients with relapsed/refractory multiple myeloma.

ABSTRACT:

SUBMITTER: Girgis S 

PROVIDER: S-EPMC9979748 | biostudies-literature | 2023 Feb

REPOSITORIES: biostudies-literature